Napean Trading & Investment Co Singapore PTE Ltd raised its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 16.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,498 shares of the conglomerate's stock after purchasing an additional 9,001 shares during the quarter. Danaher makes up about 3.9% of Napean Trading & Investment Co Singapore PTE Ltd's holdings, making the stock its 7th biggest holding. Napean Trading & Investment Co Singapore PTE Ltd's holdings in Danaher were worth $13,222,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. MGO One Seven LLC grew its position in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after buying an additional 20,813 shares during the period. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Danaher in the 1st quarter worth about $539,000. Horizon Financial Services LLC grew its position in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after buying an additional 8,160 shares during the period. Texas Capital Bank Wealth Management Services Inc grew its position in shares of Danaher by 6.1% in the 1st quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock worth $7,126,000 after buying an additional 2,009 shares during the period. Finally, EFG Asset Management Americas Corp. grew its position in shares of Danaher by 13.1% in the 1st quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after buying an additional 4,191 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Stock Performance
DHR traded up $1.29 during midday trading on Friday, hitting $200.32. 2,837,584 shares of the company traded hands, compared to its average volume of 2,853,165. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $143.44 billion, a PE ratio of 42.62, a price-to-earnings-growth ratio of 2.79 and a beta of 0.75. The company's 50-day moving average is $201.93 and its 200 day moving average is $199.31. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on DHR shares. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Wells Fargo & Company reduced their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. Evercore ISI dropped their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Finally, Robert W. Baird upped their price target on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $246.35.
Check Out Our Latest Research Report on Danaher
Insider Transactions at Danaher
In other Danaher news, Director Teri List sold 2,778 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.20% of the company's stock.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
